Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial

OBJECTIVE: To determine if extended-release naltrexone (XR-NTX) would improve or maintain viral suppression (VS) among prisoners or jail detainees with HIV and opioid use disorders (OUD) transitioning to the community. DESIGN: A four-site, prospective randomized double-blind, placebo-controlled tria...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Acquir Immune Defic Syndr
Autores principales: Springer, Sandra A., Di Paola, Angela, Azar, Marwan, Barbour, Russell, Biondi, Breanne E., Desabrais, Maureen, Lincoln, Thomas, Skiest, Daniel J., Altice, Frederick L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889326/
https://ncbi.nlm.nih.gov/pubmed/29373393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001634
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares